FindTrial
Sign In

Feasibility and safety of robotic-assisted thoracic surgery following neoadjuvant chemoimmunotherapy in non-small cell lung cancer

Feasibility and safety of robotic-assisted thoracic surgery following neoadjuvant chemoimmunotherapy in non-small cell lung cancer: a real-world cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056007
Enrollment
Unknown
Registered
2022-01-30
Start date
2020-06-01
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

case series:Nil

Sponsors

Xiangya Hospital Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Treatment-naive adult patients with histological or cytological confirmation of NSCLC; 2.Resectable or potentially resectable stage IB-III NSCLC; 3.ECOG PS score <= 2.

Exclusion criteria

Exclusion criteria: 1. Patients with active autoimmune diseases, interstitial lung diseases, active hepatitis B/C, active pulmonary tuberculosis, and immunodeficiency; 2. Patients who require systematic administration of steroids (equal to prednisone 10mg per day) or other immunosuppressants.

Design outcomes

Primary

MeasureTime frame
Major pathological response;Complete resection rate;—

Countries

China

Contacts

Public ContactMin Li

Xiangya Hospital, Central South University

limin2050@csu.edu.cn+86 13787103054

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026